Literature DB >> 20954126

[The struggle against malaria in the Ottoman Empire during World War I and the legal regulations made to this end].

Zafer Koylu1, Nihal Doğan.   

Abstract

One of the most important disadvantages of war environmental is infectious diseases. The Ottoman Empire combated infectious diseases in addition to the war because of Balkan wars and afterwards first world war. Because of increasing migrations to Anatolia after Balkan wars spread some epidemic diseases, such as cholera, typhoid fever, plaque, dysentery, syphilis. With the start of the First World War, malaria began to spread within civilian population as well as the military. The population fell from power because of illness and therefore could not process the land tax failed to pay taxes. Founded in 1914 with the fight against epidemic diseases was initiated by the Sıhhiye ministry. Quinine was formed as tablets which was imported from Germany by legal regulation and was distributed to the public by Ziraat Bank. However, malaria epidemic could not be prevented because of long war years, lack of population, insufficiency of the preventive methods and lack of quinine, and about three quarters of the population caught malaria and in four years 412.000 soldiers had malaria and 20.000 of them died despite of measures.

Entities:  

Mesh:

Year:  2010        PMID: 20954126

Source DB:  PubMed          Journal:  Turkiye Parazitol Derg        ISSN: 1300-6320


  2 in total

Review 1.  Malaria's contribution to World War One - the unexpected adversary.

Authors:  Bernard J Brabin
Journal:  Malar J       Date:  2014-12-16       Impact factor: 2.979

2.  Malaria screening at the workplace in Cameroon.

Authors:  Christian Nchetnkou Mbohou; Loick Pradel Kojom Foko; Hervé Nyabeyeu Nyabeyeu; Calvin Tonga; Larissa Kouodjip Nono; Lafortune Kangam; Godlove Wepnje Bunda; Isabelle Matip Mbou; Etoile Odette Ngo Hondt; Alex Joel Koumbo Mbe; Nicolas Policarpe Nolla; Leopold Gustave Lehman
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.